Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin

被引：98
|
作者：
Yang, Jie [1 ]
Li, Minmin [2 ]
Shen, Xintian [1 ]
Liu, Shuwen [1 ]
机构：
[1] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China
[2] Jinan Univ, Affiliated Hosp 1, Dept Clin Lab, Guangzhou 510630, Guangdong, Peoples R China
来源：
VIRUSES-BASEL | 2013年 / 5卷 / 01期
关键词：
influenza A virus; hemagglutinin; viral entry; antiviral drugs; MEDIATED MEMBRANE-FUSION; CONFORMATIONAL-CHANGE; POTENT INHIBITORS; VIRAL ATTACHMENT; RECEPTOR-BINDING; CLEAVAGE SITE; IN-VIVO; H5N1; IDENTIFICATION; GLYCOSYLATION;
D O I：
10.3390/v5010352
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Influenza A virus (IAV) has caused seasonal influenza epidemics and influenza pandemics, which resulted in serious threat to public health and socioeconomic impacts. Until now, only 5 drugs belong to two categories are used for prophylaxis and treatment of IAV infection. Hemagglutinin (HA), the envelope glycoprotein of IAV, plays a critical role in viral binding, fusion and entry. Therefore, HA is an attractive target for developing anti-IAV drugs to block the entry step of IAV infection. Here we reviewed the recent progress in the study of conformational changes of HA during viral fusion process and the development of HA-based IAV entry inhibitors, which may provide a new choice for controlling future influenza pandemics.
引用
收藏
页码：352 / 373
页数：22
相关论文
共 50 条
  • [1] Potent influenza A virus entry inhibitors targeting a conserved region of hemagglutinin
    Lin, Dongguo
    Luo, Yinzhu
    Yang, Guang
    Li, Fangfang
    Xie, Xiangkun
    Chen, Daiwei
    He, Lifang
    Wang, Jingyu
    Ye, Chunfeng
    Lu, Shengsheng
    Lv, Lin
    Liu, Shuwen
    He, Jian
    BIOCHEMICAL PHARMACOLOGY, 2017, 144 : 35 - 51
  • [2] Inhibitors Targeting the Influenza Virus Hemagglutinin
    Li, F.
    Ma, C.
    Wang, J.
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (11) : 1361 - 1382
  • [3] New Small Molecule Entry Inhibitors Targeting Hemagglutinin-Mediated Influenza A Virus Fusion
    Basu, Arnab
    Antanasijevic, Aleksandar
    Wang, Minxiu
    Li, Bing
    Mills, Debra M.
    Ames, Jessica A.
    Nash, Peter J.
    Williams, John D.
    Peet, Norton P.
    Moir, Donald T.
    Prichard, Mark N.
    Keith, Kathy A.
    Barnard, Dale L.
    Caffrey, Michael
    Rong, Lijun
    Bowlin, Terry L.
    JOURNAL OF VIROLOGY, 2014, 88 (03) : 1447 - 1460
  • [4] Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin
    Chen, Xueqing
    Si, Longlong
    Liu, Dong
    Proksch, Peter
    Zhang, Lihe
    Zhou, Demin
    Lin, Wenhan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 93 : 182 - 195
  • [5] A cell free biomembrane platform for multimodal study of influenza virus hemagglutinin and for evaluation of entry-inhibitors against hemagglutinin
    Roy, Arpita
    Byrne, Sylvester
    Sarangi, Nirod Kumar
    Murphy, Paul V. V.
    Keyes, Tia E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [6] Exploring sialic acid derivative inhibitors targeting influenza virus hemagglutinin (HA) protein
    Ghazimirsaeed, S. Erfan
    Khavani, Mohammad
    Mofrad, Mohammad
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 471A - 472A
  • [7] Cooperative activation of influenza virus hemagglutinin during viral entry
    Markovic, I
    Leikina, E
    Chernomordik, LV
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 59A - 59A
  • [8] Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
    Skehel, JJ
    Wiley, DC
    ANNUAL REVIEW OF BIOCHEMISTRY, 2000, 69 : 531 - 569
  • [9] Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
    Du, Ruikun
    Cui, Qinghua
    Rong, Lijun
    VIRUSES-BASEL, 2019, 11 (05):
  • [10] Investigational hemagglutinin-targeted influenza virus inhibitors
    Zeng, Li-Yan
    Yang, Jie
    Liu, Shuwen
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (01) : 63 - 73
12345